These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24992980)

  • 41. Large Animal Models for the Clinical Application of Human Induced Pluripotent Stem Cells.
    Cong X; Zhang SM; Ellis MW; Luo J
    Stem Cells Dev; 2019 Oct; 28(19):1288-1298. PubMed ID: 31359827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
    Fan Y; Winanto ; Ng SY
    Transl Neurodegener; 2020; 9():2. PubMed ID: 31911835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation of polyhormonal and multipotent pancreatic progenitor lineages from human pluripotent stem cells.
    Korytnikov R; Nostro MC
    Methods; 2016 May; 101():56-64. PubMed ID: 26515645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Self-renewal and cell lineage differentiation strategies in human embryonic stem cells and induced pluripotent stem cells.
    Efthymiou AG; Chen G; Rao M; Chen G; Boehm M
    Expert Opin Biol Ther; 2014 Sep; 14(9):1333-44. PubMed ID: 24881868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical potentials of human pluripotent stem cells.
    Mora C; Serzanti M; Consiglio A; Memo M; Dell'Era P
    Cell Biol Toxicol; 2017 Aug; 33(4):351-360. PubMed ID: 28176010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autologous stem cell therapy for inherited and acquired retinal disease.
    Apatoff MBL; Sengillo JD; White EC; Bakhoum MF; Bassuk AG; Mahajan VB; Tsang SH
    Regen Med; 2018 Jan; 13(1):89-96. PubMed ID: 29360008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concise review: cell therapy and tissue engineering for cardiovascular disease.
    Haraguchi Y; Shimizu T; Yamato M; Okano T
    Stem Cells Transl Med; 2012 Feb; 1(2):136-41. PubMed ID: 23197760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploiting pluripotency for therapeutic gain.
    Deng W
    Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Human Endocrine Pancreas: New Insights on Replacement and Regeneration.
    Domínguez-Bendala J; Lanzoni G; Klein D; Álvarez-Cubela S; Pastori RL
    Trends Endocrinol Metab; 2016 Mar; 27(3):153-162. PubMed ID: 26774512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stem cells create a therapeutic niche.
    Dangi-Garimella S
    Am J Manag Care; 2014 May; 20(8 Spec No.):E7. PubMed ID: 25617926
    [No Abstract]   [Full Text] [Related]  

  • 52. iPS cells--alternative pluripotent cells to embryo stem cells.
    Pei X
    Sci China Life Sci; 2010 Jan; 53(1):154-156. PubMed ID: 20596969
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine.
    Oh Y; Wei H; Ma D; Sun X; Liew R
    Heart; 2012 Mar; 98(6):443-9. PubMed ID: 22285968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stem cell-based treatment of kidney diseases.
    Pan B; Fan G
    Exp Biol Med (Maywood); 2020 May; 245(10):902-910. PubMed ID: 32281411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Future prospects for regenerated heart using induced pluripotent stem cells.
    Fujita J; Fukuda K
    J Pharmacol Sci; 2014; 125(1):1-5. PubMed ID: 24739283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induced pluripotent stem cells: a new technology to study human diseases.
    Vitale AM; Wolvetang E; Mackay-Sim A
    Int J Biochem Cell Biol; 2011 Jun; 43(6):843-6. PubMed ID: 21458591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human embryonic stem cells vs human induced pluripotent stem cells for cardiac repair.
    Barad L; Schick R; Zeevi-Levin N; Itskovitz-Eldor J; Binah O
    Can J Cardiol; 2014 Nov; 30(11):1279-87. PubMed ID: 25442431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concise review: hurdles in a successful example of limbal stem cell-based regenerative medicine.
    Pellegrini G; Rama P; Di Rocco A; Panaras A; De Luca M
    Stem Cells; 2014 Jan; 32(1):26-34. PubMed ID: 24038592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. From Pituitary Stem Cell Differentiation to Regenerative Medicine.
    Camilletti MA; Martinez Mayer J; Vishnopolska SA; Perez-Millan MI
    Front Endocrinol (Lausanne); 2020; 11():614999. PubMed ID: 33542708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An overview on stem cell research: a report on the 7th Annual Meeting of the International Society for Stem Cell Research.
    Romano G
    Drug News Perspect; 2009 Oct; 22(8):504-8. PubMed ID: 20016860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.